fbpx

ImmunoGen Announces Conference Call to Discuss Its First Quarter 2019 Operating Results

WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen,
Inc.
, (Nasdaq: IMGN), a leader in the expanding field of
antibody-drug conjugates (ADCs) for the treatment of cancer, today
announced that the Company will host a conference call at 8:00 a.m. ET
on Friday, May 3, 2019 to discuss its first quarter operating results.
Management will also provide a brief update on the business.

Conference Call Information
To access the live call by
phone, dial 323-994-2093; the conference ID is 8980567. The call may
also be accessed through the Investors and Media section of the
Company’s website, www.immunogen.com.
Following the webcast, a replay of the call will be available at the
same location through May 17, 2019.

ABOUT IMMUNOGEN
ImmunoGen is developing the next generation
of antibody-drug conjugates (ADCs) to improve outcomes for cancer
patients. By generating targeted therapies with enhanced anti-tumor
activity and favorable tolerability profiles, we aim to disrupt the
progression of cancer and offer our patients more good days. We call
this our commitment to “target a better now.” The Company has built a
productive platform generating a broad pipeline of ADCs targeting solid
tumors and hematologic malignancies.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

Contacts

INVESTOR RELATIONS CONTACT
Sarah Kiely
781-895-0600
[email protected]

MEDIA
CONTACT

Courtney O’Konek
781-895-0600
[email protected]

OR

FTI
Consulting
Robert Stanislaro
212-850-5657
[email protected]

leverton

Content is the most important part of having quality links to your website. With Area-Info.net, we provide a quality location to share your story and include links to your website to help you grow. If you would like to learn more, visit this page to see how you can use Area-Info.net to rank higher and quicker in search engines. Contact me directly at [email protected] with any questions, or to schedule speaking engagements.

You May Also Like